Predictors of survival trajectories among women with epithelial ovarian cancer
Lauren C. Peres(Moffitt Cancer Center), Shelley S. Tworoger(Oregon Health & Science University), Eileen H. Shinn(The University of Texas MD Anderson Cancer Center), Mary K. Townsend(Moffitt Cancer Center), Susan K. Lutgendorf(University of Iowa), Beth Y. Karlan(University of California, Los Angeles), Brooke L. Fridley(Children's Mercy Hospital), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Sweta Sinha(Unknown)
Cited by 41
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension
|Hypertension|2007|898